These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 26369546

  • 21. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.
    Lee J, Park M, Lee MH, Woo HJ, Kim HW, Yang JY, Eom YB, Kim SH, Yoo C, Kim JB.
    Int J Clin Exp Pathol; 2015; 8(7):7859-68. PubMed ID: 26339350
    [Abstract] [Full Text] [Related]

  • 22. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z, Hu L, Yao M, He C, Liu Q, Wang F, Gu W, Wang Y, Dong M, Zhu T, Yin T, Li F, Jin Y, Huang S, Zhang H, Sang W, Huaihai Lymphoma Working Group (HHLWG).
    Int J Cancer; 2022 Jan 15; 150(2):327-334. PubMed ID: 34520566
    [Abstract] [Full Text] [Related]

  • 23. [CD5 expression is an adverse prognostic factor in diffuse large B-cell lymphoma].
    Zheng Y, Ma XB, Jiang J, Wang YP.
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar 15; 41(3):156-60. PubMed ID: 22800477
    [Abstract] [Full Text] [Related]

  • 24. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.
    Acta Oncol; 2014 May 15; 53(5):669-79. PubMed ID: 24164103
    [Abstract] [Full Text] [Related]

  • 25. [The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma].
    Zhao Q, Fu WJ, Zhang CY, Du J, Xi H, Hou J.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep 15; 34(9):737-40. PubMed ID: 24103868
    [Abstract] [Full Text] [Related]

  • 26. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E, Papavassiliou P, Sebastian S.
    Pathol Res Pract; 2012 Jun 15; 208(6):363-7. PubMed ID: 22572037
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma.
    Tang H, Zhou H, Wei J, Liu H, Qian W, Chen X.
    Hematology; 2019 Dec 15; 24(1):446-454. PubMed ID: 31072235
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
    Monabati A, Vahedi A, Safaei A, Noori S, Mokhtari M, Vahedi L, Zamani M.
    Asian Pac J Cancer Prev; 2016 Dec 15; 17(4):2285-9. PubMed ID: 27221931
    [Abstract] [Full Text] [Related]

  • 30. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
    Hyo R, Tomita N, Takeuchi K, Aoshima T, Fujita A, Kuwabara H, Hashimoto C, Takemura S, Taguchi J, Sakai R, Fujita H, Fujisawa S, Ogawa K, Motomura S, Suzuki R, Ishigatsubo Y.
    Hematol Oncol; 2010 Mar 15; 28(1):27-32. PubMed ID: 19358143
    [Abstract] [Full Text] [Related]

  • 31. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ, Jiang WQ, Lin TY, Xia ZJ, Cai QQ.
    Chin J Cancer; 2017 Dec 16; 36(1):94. PubMed ID: 29246182
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
    Miller IJ.
    Appl Immunohistochem Mol Morphol; 2019 Mar 16; 27(3):165-173. PubMed ID: 28800008
    [Abstract] [Full Text] [Related]

  • 34. Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Lu CH, Lee KF, Chen CC, Chen YY, Huang CE, Tsai PS, Tsou HY, Chou HJ, Chen MF, Chen PT, Lee KD, Lung J.
    Jpn J Clin Oncol; 2014 Dec 16; 44(12):1164-71. PubMed ID: 25320341
    [Abstract] [Full Text] [Related]

  • 35. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
    Cassim S, Antel K, Chetty DR, Oosthuizen J, Opie J, Mohamed Z, Verburgh E.
    Pathology; 2020 Jun 16; 52(4):453-459. PubMed ID: 32305135
    [Abstract] [Full Text] [Related]

  • 36. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
    Hong JY, Yoon DH, Suh C, Huh J, Do IG, Sohn I, Jo J, Jung SH, Hong ME, Yoon H, Ko YH, Kim SJ, Kim WS.
    Ann Oncol; 2015 Mar 16; 26(3):548-55. PubMed ID: 25475080
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, German High-Grade Lymphoma Study Group.
    J Clin Oncol; 2017 Aug 01; 35(22):2515-2526. PubMed ID: 28525305
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
    De Paepe P, Achten R, Verhoef G, Wlodarska I, Stul M, Vanhentenrijk V, Praet M, De Wolf-Peeters C.
    J Clin Oncol; 2005 Oct 01; 23(28):7060-8. PubMed ID: 16129841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.